✦ LIBER ✦

Randomized Study of Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Inappropriate Conclusions

✍ Scribed by Andrea Messori; Valeria Fadda; Sabrina Trippoli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab and Bevacizumab for Neovascu

📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 679 KB

Bevacizumab vs Ranibizumab for Age-Relat

✍ Manju L. Subramanian; Steven Ness; Gelareh Abedi; Ednan Ahmed; Mary Daly; Edward 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Bevacizumab vs Ranibizumab for Age-Relat

✍ Sean P. Donahue; Franco Recchia; Paul Sternberg Jr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Intravitreal Bevacizumab and Ranibizumab

✍ Donald S. Fong; Peter Custis; Jennifer Howes; Jin-Wen Hsu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Bevacizumab vs ranibizumab for age-relat

✍ Subramanian, M L; Abedi, G; Ness, S; Ahmed, E; Fenberg, M; Daly, M K; Houranieh, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB

Ranibizumab treatment for neovascular ag

✍ Michalova, K; Wickremasinghe, S S; Tan, T H; Chang, A; Harper, C A; Downie, J A; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 273 KB